Kesios Therapeutics' Seed VC Round

Kesios Therapeutics raised a round of funding on October 08, 2014. Investors include Touchstone Innovations.

Kesios Therapeutics is developing novel therapeutics for the treatment of multiple myeloma and other cancers. KES-0001, the company's lead drug candidate, is about to enter clinical studies as a poten…

Articles about Kesios Therapeutics' Seed VC Round: